Amyl Nitrite
Amyl Nitrite is a rapidly acting organic nitrite that causes blood vessels to relax, producing vasodilation and reducing vascular resistance. Historically, it has been used for the rapid relief of angina pectoris, although it has largely been replaced by other treatments. In specific medical settings, nitrites may also have a role in cyanide poisoning management, but amyl nitrite is not a routine first-line treatment and must be used only under appropriate medical guidance. It is generally administered by inhalation in formulations intended for that route, with effects occurring rapidly and lasting for a relatively short duration. Adverse effects may include headache, flushing, dizziness, low blood pressure, and a rapid heartbeat. Serious risks include fainting, methemoglobinemia, and dangerously low blood pressure, particularly when combined with phosphodiesterase-5 inhibitors such as sildenafil or tadalafil. Amyl nitrite should be handled with caution and used only for an appropriate, medically supervised indication.
Amyl Nitrite was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Amyl Nitrite, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Amyl Nitrite from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Amyl Nitrite, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
